Assessment of Digital Health Technologies in the Asia Pacific Region

June 8, 2023

Back to all webinars

Open to all ISPOR Members and Non-members

Title: Assessment of Digital Health Technologies in the Asia Pacific Region

Thursday, June 8, 2023
9:00PM EDT

Click here for time zone conversion

Register Now


The World Health Organization recommended in 2021 that all countries should have a digital health strategy after the start of the COVID-19 pandemic. This pandemic effectively accelerated the use of digital health technologies globally, both on the part of the patient and on the part of the digital health developers. The use of mobile applications for monitoring health or teleconsults, especially in more rural areas, has grown exponentially since the start of the pandemic. This explosion of growth has led to a number of challenges for both health technology assessment (HTA) bodies and digital health developers.

This webinar is based off discussions that were held at the 2023 ISPOR HTA Roundtable – Asia Pacific on 8 March 2023. The HTA Roundtable focused on how countries or jurisdictions in the Asia Pacific region are assessing digital health technologies. This webinar will provide perspectives from different stakeholders and jurisdictions on the status of digital health assessments in the region.

The purpose of the ISPOR HTA Roundtables is to provide a platform for discussion only among HTA bodies, public and private payers, other governmental decision makers, and academics when no HTA body exists in the country. The goal is to advance the application of research on health technologies and to promote a valuable exchange of information, methods, and knowledge in the development of value assessment, or health technology assessment, in 5 major regions of the world (Asia Pacific, Europe, Latin America, Middle East and Africa, and North America.) Click here for additional information on the ISPOR HTA Roundtables.

Learning Objectives

• Learn the perspective of a digital health developer on their experience receiving regulatory approval and reimbursement of digital health technologies.
• Learn from different countries or jurisdictions in the Asia Pacific the status of assessing digital health technologies.
• Learn how Asia Pacific is assessing digital health technologies and how this may be applicable to other regions.


Izzuna Mudla Mohamed Ghazali, MBBS, MPH, Head, Malaysian Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health, Kuala Lumpur, Malaysia

Varun Veigas, Regional Regulatory Affairs and Policy Lead, Roche Diagnostics Asia Pacific, Singapore, Singapore

Harsha Rajasimha, PhD, Founder and CEO, IndoUSRare, Washington, DC, USA

Haeyeon Yoo, Researcher, New Health Technology Assessment Department, National Evidence-Based Healthcare Collaborating Agency (NECA), Seoul, South Korea

Alima Almadiyeva, MD, MScDeputy Chairperson, Salidat Kairbekova National Research Center for Health Development (NRCHD), Ministry of Health, Astana, Kazakhstan

Brought to you by: ISPOR Health Technology Assessment Roundtables

Please note:
On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.

Reservations are on a first-come, first-served basis.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now